BusinessDermira Presents Data from DRM04 Phase 3 Clinical Program in Late-Breaking News Session at European Academy of Dermatology and Venereology CongressBy Nasdaq OMXOct 1, 2016, 7:05 AM UTC
BusinessDermira to Present Data from DRM04 Phase 3 Clinical Trials at Late-Breaking News Session at European Academy of Dermatology and Venereology CongressBy Nasdaq OMXSep 28, 2016, 11:30 AM UTC
BusinessDermira Licenses DRM04 to Maruho for Hyperhidrosis in JapanBy Nasdaq OMXSep 20, 2016, 8:05 PM UTC
BusinessDermira Acquires Option to License Exclusive Rights for up to Three Early-Stage Programs from TakedaBy Nasdaq OMXSep 12, 2016, 11:30 AM UTC
BusinessDermira to Present at 15th Annual Needham Healthcare ConferenceBy Nasdaq OMXApr 5, 2016, 11:30 AM UTC
BusinessCORRECTION: The Roxbury Institute Hosts Grand Opening Party in Beverly Hills, CaliforniaBy Nasdaq OMXMar 22, 2016, 5:44 PM UTC
BusinessDermira’s Co-founder and Chief Medical Officer, Eugene A. Bauer, M.D., Receives Presidential Citation from the American Academy of DermatologyBy Nasdaq OMXMar 14, 2016, 11:30 AM UTC
BusinessDermira Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate UpdateBy Nasdaq OMXMar 3, 2016, 12:30 PM UTC
